| Name | Baloxavir |
|---|---|
| Synonyms |
(12aR)-12-[(11S)-7,8-Difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-yl]-7-hydroxy-3,4,12,12a-tetrahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione
1H-[1,4]Oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione, 12-[(11S)-7,8-difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-yl]-3,4,12,12a-tetrahydro-7-hydroxy-, (12aR)- 4G86Y4JT3F |
| Description | Baloxavir is an anti-influenza agent extracted from patent WO 2017104691 A1. |
|---|---|
| Related Catalog | |
| Target |
Influenza virus[1] |
| References |
| Density | 1.6±0.1 g/cm3 |
|---|---|
| Boiling Point | 644.7±65.0 °C at 760 mmHg |
| Molecular Formula | C24H19F2N3O4S |
| Molecular Weight | 483.487 |
| Flash Point | 343.7±34.3 °C |
| Exact Mass | 483.106445 |
| LogP | 1.51 |
| Vapour Pressure | 0.0±2.0 mmHg at 25°C |
| Index of Refraction | 1.757 |
| Storage condition | 2-8℃ |